TY - JOUR AU - Kokane, Vibhavari AU - Pawar, Vinay PY - 2019/09/16 Y2 - 2024/03/29 TI - Comparative Clinical Assessment of Efficacy of Shataputi Abhrak Bhasma Along With Chausasti Pippali as an Adjuvant to AKT in Pulmonary TB JF - Ayurline: International Journal of Research in Indian Medicine JA - IJ-RIM VL - 3 IS - 04 SE - Original Research Articles DO - UR - https://ayurline.in/index.php/ayurline/article/view/275 SP - AB - <p>Worldwide, tuberculosis (TB) is one of the top 10 causes of death, and the leading cause from a single infectious agent. It has been reported that millions of people continue to fall sick with TB each year. Since 1994, with endorsement from WHO; DOTS, Directly Observed Treatment Short-course strategy has been implemented worldwide for control of TB. However, the increasing incidence of TB suggests the need for newer medicines, especially from Ayurveda. <em>Rajayakshma</em>&nbsp;has been correlated with pulmonary tuberculosis due to a great deal of similarities in their manifestations. <em>Abhraka Bhasma </em>and <em>Chausasti Pippali</em>&nbsp;are widely used by Ayurvedic physicians for the treatment of various respiratory diseases. This study was designed to elucidate their anti-tubercular efficacy as an adjuvant to DOTS therapy. The study was conducted on 60 patients diagnosed with Pulmonary TB and showing signs and symptoms of <em>Rajayakshma. </em>They were divided into two groups<em>. </em>The study duration was two months<em>.</em>&nbsp;As per the observations, it was seen that, though both groups were receiving anti-tubercular drugs; the response in the group B patients (DOTS with <em>Shataputi</em>&nbsp;<em>Abhraka</em>&nbsp;<em>Bhasma</em>&nbsp;and <em>Chausasti</em>&nbsp;<em>Pippali</em>) was comparatively better and earlier in some of the symptoms studied. The subjective feeling of the sense of well being was enhanced and reported earlier by the patients of Group B. It can be concluded that co-administration of <em>Shataputi</em>&nbsp;<em>Abhrak</em>&nbsp;<em>Bhasma</em>&nbsp;and <em>Chausasti</em>&nbsp;<em>Pippali</em>&nbsp;along with AKT provided better outcome.</p> ER -